Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Lupin Ltd.
NSE: LUPIN
|
BSE: 500257
|
ISIN: INE326A01037
|
Industry: Pharmaceuticals
US FDA Observation
|
Mid-range Performer
2034.8000
-17.00
(
-0.83
%)
NSE
Sep 17, 2025
14:26 PM
Volume:
526.5K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Lupin Ltd.
11 Nov 2022
US FDA Observation
2034.80
-0.83%
Lupin (HOLD): Return to double-digit margins
Hold:
Lupin Ltd.
by
BOB Capital Markets Ltd.
Target: 700
Recommendation
Target
BOB Capital Markets Ltd.
Q2 revenue grew 11% QoQ (+1% YoY) with recovery in US business and continued momentum in India
Number of FII/FPI investors increased from 979 to 987 in Jun 2025 qtr.
More from Lupin Ltd.
Recommended
Market trades higher, L&T bags power orders worth over Rs 2,500 crore
Trendlyne Marketwatch |
17 Sep 2025, 02:08PM
Five stocks to buy from analysts this week - September 16, 2025
The Baseline |
16 Sep 2025, 06:08PM
Lupin expects normalization by September quarter
|
17 Apr 2020